전립선비대증 환자에서 술 전 전립선특이항원치 4 ng/ml 기준으로 경요도전립선절제술 후에 발생하는 전립선특이항원의 감소치 비교 및 의의 = Comparision of Prostate-specific Antigen Reduction after Performing Transurethral Resection of the Prostate according to a Preoperative Prostate-specific Antigen Value of 4 ng/ml

다국어 초록 (Multilingual Abstract)

Purpose: We compared prostate-specific antigen (PSA) reduction after performing transurethral resection of the prostate (TURP) according to a preoperative PSA value of 4 ng/ml and analyzed the meaning of elevation of the preoperative PSA value over 4 ng/ml.
Materials and Methods: We investigated the PSA level and prostate volume by transrectal ultrasonography (TRUS), urine flow rate, residual urine volume, and international prostate symptom score (IPSS) preoperatively and at 1 year after performing TURP in 61 clinically diagnosed BPH patients who had lower urinary tract symptoms (LUTS). We enrolled the 61 patients into 2 groups according to their preoperative PSA level relative to 4 ng/ml and compared the PSA reduction ratio (postoperative PSA level/preoperative PSA level), prostate volume reduction ratio, preoperative prostate volume, resected prostate volume, preoperative residual urine volume, preoperative maximal flow rate, and IPSS in each group.
Results: In the preoperative PSA group ≥4 ng/ml, the PSA reduction ratio was significantly lower than the PSA group ＜4 ng/ml and there were significant differences between the two groups in total IPSS, obstructive score, and preoperative maximal urine flow rate but no significant differences in preoperative prostate volume, prostate volume reduction ratio, or resected prostate volume.
Conclusions: Marked PSA reduction after performing TURP was achieved in members of the preoperative PSA group ≥4 ng/ml, who are expected to have more severe bladder outlet obstruction (BOO).

참고문헌 (Reference)

1 원종진, "경요도전립선절제술 후 절제 전립선 용적과 혈청 전립선 특이항원 변화의 임상적 의미" 대한비뇨기과학회 46 (46): 704-707, 2005

2 정승일, "경요도전립선절제술 1년 후 전립선특이항원 변화" 대한비뇨기과학회 48 (48): 691-695, 2007

3 Roehrborn CG, "The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia" 20 (20): S19-26, 2008

4 Laniado ME, "Serum prostate-specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms" 94 : 1283-1286, 2004

5 Roehrborn CG, "Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia" 53 : 581-589, 1999

6 Marks LS, "Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia" 156 : 1035-1039, 1996

7 van Renterghem K, "Rising PSA in patients with minor LUTS without evidence of prostatic carcinoma: a missing link?" 39 : 1107-1113, 2007

8 Collins GN, "Relationship between prostate specific antigen, prostate volume and age in the benign prostate" 71 : 445-450, 1993

9 Fonseca RC, "Prostate specific antigen levels following transurethral resection of the prostate" 34 : 41-48, 2008

10 Wang MC, "Prostate antigen: a new potential marker for prostatic cancer" 2 : 89-96, 1981

11 이승언, "PSA 상승과 무증상 전립선염: 병리소견과의 연관성" 대한비뇨기과학회 47 (47): 31-36, 2006

12 Reis LO, "Intravesical protrusion of the prostate as a predictive method of bladder outlet obstruction" 34 : 627-633, 2008

13 Aus G, "Influence of benign prostatic hyperplasia, testosterone and age on serum levels of prostate specific antigen" 28 : 379-384, 1994

14 Bantis A, "Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia" 10 : 138-143, 2007

15 Ezz el Din K, "Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score" 48 : 393-397, 1996

16 van Renterghem K, "Clinical relevance of transurethral resection of the prostate in “asymptomatic” patients with an elevated prostate-specific antigen level" 52 : 819-826, 2007

17 Emberton M, "Benign prostatic hyperplasia: a progressive disease of aging men" 61 : 267-273, 2003